Byung-Hyun Lee

Korea University College of Medicine and School of Medicine

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Immunology Immunology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Dae Hee Kim

SOUTH KOREA

View details

Jae Seung Jung

Professor

Yeungnam University Medical Center

SOUTH KOREA

View details

Yong Park

Seoul National University Hospital

SOUTH KOREA

View details

Jongseong Kim

Research Professor

Korea University

SOUTH KOREA

View details

Ki Ahn

Yonsei University College of Medicine

SOUTH KOREA

View details

Dongwon Yoo

Assistant Professor

Seoul National University

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Byung-Hyun Lee

Research Interests

Explore related searches

Contact this professor

Articles (11)

Blood Transfusion, All-Cause Mortality and Hospitalization Period in COVID-19 Patients: Machine Learning Analysis of National Health Insurance Claims Data

PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma

Postoperative Thromboembolism According to the Type of Surgery: A Nationwide Study in the Republic of Korea

Clinical Efficacy of Ruxolitinib in Patients with Myelofibrosis: A Nationwide Population-Based Study in Korea

A novel anti-pd-l1 antibody exhibits antitumor effects on multiple myeloma in murine models via antibody-dependent cellular cytotoxicity

New Tool for Rapid and Accurate Detection of Interleukin-2 and Soluble Interleukin-2 Receptor α in Cancer Diagnosis Using a Bioresponsive Microgel and Multivalent Protein Binding

Prediction Model for Cereblon Expression in Bone Marrow Plasma Cells Based on Blood Markers in Multiple Myeloma Patients

Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma

Efficacy and safety of two pegfilgrastim biosimilars: Tripegfilgrastim and pegteograstim

Comparison between 5-day decitabine and 7-day azacitidine for lower-risk myelodysplastic syndromes with poor prognostic features: a retrospective multicentre cohort study

Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q deletion and IGH translocation

Collaborators (6)

Dae Hee Kim

Jae Seung Jung

Yong Park

Jongseong Kim

Ki Ahn

Dongwon Yoo

Make your next move.